In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells

By Nahta Rita   Esteva Francisco  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite

The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells

By Vazquez-Martin Alejandro   Oliveras-Ferraros Cristina   Barco Sonia   Martin-Castillo Begoña   Menendez Javier  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 355-364

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

By Yonemori Kan   Katsumata Noriyuki   Uno Hajime   Matsumoto Koji   Kouno Tsutomu   Tokunaga Shinya   Yamanaka Yasuhiro   Shimizu Chikako   Ando Masashi   Takeuchi Masahiro   Fujiwara Yasuhiro  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 237-241

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

By Jerusalem Guy   Fasolo Angelica   Dieras Veronique   Cardoso Fatima   Bergh Jonas   Vittori Luc   Zhang Yufen   Massacesi Cristian   Sahmoud Tarek   Gianni Luca  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 447-455

Springer Publishing Company

Access to resources Recommend Favorite